Effects of FT011 in Systemic Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
FT011 is an anti-fibrotic drug that is being tested as a treatment for scleroderma. This study is being conducted to see what the body does to the drug (pharmacokinetics), and what the drug does to the body (pharmacodynamics).
Epistemonikos ID: ebbf12ec116c91fe917a4a0d004cc7e712a87010
First added on: May 07, 2024